Medical Scientist Training Program - Ohio State University

医学科学家培训计划 - 俄亥俄州立大学

基本信息

  • 批准号:
    8501526
  • 负责人:
  • 金额:
    $ 29.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-07-01 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The fundamental mission of academic medicine is the acquisition and application of scientific knowledge to improve health care. In order for the medical enterprise to function effectively, it is critically important for the academic biomedical community to have physician-scientists who receive special training that integrates both a rigorous scientific education with state-of-the-art medical education. These individuals facilitate interactions between the clinic and lab that promote both basic investigation on disease mechanisms and translational research leading to clinical applications. Thus, they are positioned to be leaders in biomedical research and educational communities. In this MSTP application, we describe The Ohio State University (OSU) Medical Scientist Program (MSP), whose objective is to provide MD-PhD trainees with the rigor, depth, and breadth of both scientific and medical education in a way that facilitates integrating both sets of training to prepare them for careers as successful physician-scientists. In order to achieve these goals, the MSP serves as a partnership program linking an innovative medical school curriculum with three integrated graduate programs to allow students to pursue in-depth scientific inquiry in a wide variety of areas. Medical school coursework is completed using OSU's Independent Study Program, a unique classroom- independent course of study which enables students to use structured objectives and distributed sources of information to learn the pre-clinical medical curriculum. At the same time, students begin their PhD training by taking graduate courses in one of three specific programs, the Integrated Biomedical Science Graduate Program (IBGP), the Neuroscience Graduate Studies Program (NGSP), or Biomedical Engineering (BME). By beginning coursework in both areas simultaneously, students receive much better integration of content than would be achieved by studying the material sequentially. In addition, this engineered integrated approach means that students have completed nearly all their coursework by the end of two years in the program. Beginning in the third year, students can devote the bulk of their time to their dissertation research, enabling them to complete their studies in a time-efficient manner typically lasting 8 years. This highly integrated MD-PhD program has attracted interest from a large pool of excellent applicants for the 5 positions that we fill annually. We are requesting funds for 30 student years of funding over 5 years beginning with 2 in the first year and adding 2 each year to a total of 10 in year 5. Recognition of our program by NIGMS will allow us to recruit the best and brightest students, enhancing the ability of the MSP to train the future leaders who will enable the Ohio State University College of Medicine to achieve its stated mission: To improve people's lives through innovation in research, education and patient care.
描述(由申请人提供):学术医学的基本使命是获取和应用科学知识来改善医疗保健。为了使医疗企业有效运作,学术生物医学界拥有接受过将严格的科学教育与最先进的医学教育相结合的特殊培训的医师科学家至关重要。这些人促进诊所和实验室之间的互动,促进疾病机制的基础研究和临床应用的转化研究。因此,他们被定位为生物医学研究和教育界的领导者。在此 MSTP 应用程序中,我们描述了俄亥俄州立大学 (OSU) 医学科学家计划 (MSP),其目标是为 MD-PhD 学员提供科学和医学教育的严谨性、深度和广度,以促进整合两套培训,为他们成为成功的医师科学家的职业生涯做好准备。为了实现这些目标,MSP 作为一个合作伙伴计划,将创新的医学院课程与三个综合研究生课程联系起来,使学生能够在各个领域进行深入的科学探究。医学院的课程作业是使用俄勒冈州立大学的独立学习计划完成的,这是一种独特的课堂独立学习课程,使学生能够使用结构化目标和分布式信息源来学习临床前医学课程。同时,学生通过参加三个特定项目之一的研究生课程开始博士学位培训,即综合生物医学科学研究生项目 (IBGP)、神经科学研究生项目 (NGSP) 或生物医学工程 (BME)。通过同时开始这两个领域的课程,学生可以获得比顺序学习材料更好的内容整合。此外,这种工程化的综合方法意味着学生在项目两年结束时已经完成了几乎所有的课程作业。从第三年开始,学生可以将大部分时间投入论文研究,从而使他们能够高效地完成通常持续 8 年的学习。这个高度整合的医学博士-博士项目吸引了大批优秀申请者对我们每年填补的 5 个职位的兴趣。我们正在申请为期 5 年的 30 个学生年资助,从第一年 2 个开始,每年增加 2 个,到第 5 年总计 10 个。NIGMS 对我们项目的认可将使我们能够招收最优秀和最聪明的学生,增强 MSP 培训未来领导者的能力,使俄亥俄州立大学医学院能够实现其既定使命:通过研究、教育和患者护理方面的创新来改善人们的生活。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Larry S. Schlesinger其他文献

Mycobacterium tuberculosis remodels host transcriptome
结核分枝杆菌重塑宿主转录组
  • DOI:
    10.1038/s41564-021-01056-x
  • 发表时间:
    2022-01-31
  • 期刊:
  • 影响因子:
    19.400
  • 作者:
    Melanie A. Carless;Larry S. Schlesinger
  • 通讯作者:
    Larry S. Schlesinger
Identifying Mycobacterium tuberculosis virulence determinants - new technologies for a difficult problem.
识别结核分枝杆菌毒力决定因素——解决难题的新技术。
  • DOI:
  • 发表时间:
    2000
  • 期刊:
  • 影响因子:
    15.9
  • 作者:
    Lucy E. Desjardin;Larry S. Schlesinger
  • 通讯作者:
    Larry S. Schlesinger
Antibody-independent classical complement pathway activation by wildtype and LPS O-antigen mutant <em>Francisella tularensis</em> strains
  • DOI:
    10.1016/j.molimm.2010.05.146
  • 发表时间:
    2010-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Corey D. Clay;John S. Gunn;Larry S. Schlesinger
  • 通讯作者:
    Larry S. Schlesinger
Timing matters in macrophage/CD4+ T cell interactions: an agent-based model comparing emMycobacterium tuberculosis/em host-pathogen interactions between latently infected and naïve individuals
时机在巨噬细胞/CD4+T 细胞相互作用中很重要:一个基于代理的模型比较了潜伏感染和未感染个体之间的结核分枝杆菌宿主-病原体相互作用
  • DOI:
    10.1128/msystems.01290-24
  • 发表时间:
    2025-02-27
  • 期刊:
  • 影响因子:
    4.600
  • 作者:
    Alexis Hoerter;Alexa Petrucciani;Jordan Bonifacio;Eusondia Arnett;Larry S. Schlesinger;Elsje Pienaar
  • 通讯作者:
    Elsje Pienaar
Impact of the elderly lung mucosa on emMycobacterium tuberculosis/em transcriptional adaptation during infection of alveolar epithelial cells
老年肺黏膜对肺泡上皮细胞感染期间结核分枝杆菌转录适应性的影响
  • DOI:
    10.1128/spectrum.01790-24
  • 发表时间:
    2024-10-30
  • 期刊:
  • 影响因子:
    3.800
  • 作者:
    Angélica M. Olmo-Fontánez;Anna Allué-Guardia;Andreu Garcia-Vilanova;Jeremy Glenn;Shu-Hua Wang;Robert E. Merritt;Larry S. Schlesinger;Joanne Turner;Yufeng Wang;Jordi B. Torrelles
  • 通讯作者:
    Jordi B. Torrelles

Larry S. Schlesinger的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Larry S. Schlesinger', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    10431466
  • 财政年份:
    2022
  • 资助金额:
    $ 29.79万
  • 项目类别:
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
跨学科 NexGen 结核病研究推进中心 (IN-TRAC)
  • 批准号:
    10588203
  • 财政年份:
    2022
  • 资助金额:
    $ 29.79万
  • 项目类别:
Clinical Research & Patient Care Core (CRPCC)
临床研究
  • 批准号:
    10431471
  • 财政年份:
    2022
  • 资助金额:
    $ 29.79万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10588204
  • 财政年份:
    2022
  • 资助金额:
    $ 29.79万
  • 项目类别:
Interdisciplinary NexGen TB research Advancement Center (IN-TRAC)
跨学科 NexGen 结核病研究推进中心 (IN-TRAC)
  • 批准号:
    10431465
  • 财政年份:
    2022
  • 资助金额:
    $ 29.79万
  • 项目类别:
Clinical Research & Patient Care Core (CRPCC)
临床研究
  • 批准号:
    10588232
  • 财政年份:
    2022
  • 资助金额:
    $ 29.79万
  • 项目类别:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
健康和结核分枝杆菌感染期间的巨噬细胞核受体、代谢和免疫效应器
  • 批准号:
    10450960
  • 财政年份:
    2020
  • 资助金额:
    $ 29.79万
  • 项目类别:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection
健康和结核分枝杆菌感染期间的巨噬细胞核受体、代谢和免疫效应器
  • 批准号:
    10457308
  • 财政年份:
    2019
  • 资助金额:
    $ 29.79万
  • 项目类别:
Macrophage nuclear receptors, metabolism and immune effectors during health and M. tuberculosis infection- Diversity Supplement
健康和结核分枝杆菌感染期间的巨噬细胞核受体、代谢和免疫效应器 - Diversity Supplement
  • 批准号:
    10116937
  • 财政年份:
    2019
  • 资助金额:
    $ 29.79万
  • 项目类别:
Expansion of Marmoset Breeding Facilities to Meet Increasing Research Demands
扩建狨猴饲养设施以满足不断增长的研究需求
  • 批准号:
    9933536
  • 财政年份:
    2019
  • 资助金额:
    $ 29.79万
  • 项目类别:

相似海外基金

Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
  • 批准号:
    10681215
  • 财政年份:
    2021
  • 资助金额:
    $ 29.79万
  • 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
  • 批准号:
    10270657
  • 财政年份:
    2021
  • 资助金额:
    $ 29.79万
  • 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
  • 批准号:
    10430249
  • 财政年份:
    2021
  • 资助金额:
    $ 29.79万
  • 项目类别:
Medical Scientist Training Program - The Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
  • 批准号:
    10438948
  • 财政年份:
    2021
  • 资助金额:
    $ 29.79万
  • 项目类别:
Medical Scientist Training Program-Ohio State University
医学科学家培训项目-俄亥俄州立大学
  • 批准号:
    9433923
  • 财政年份:
    2011
  • 资助金额:
    $ 29.79万
  • 项目类别:
Medical Scientist Training Program-Ohio State University
医学科学家培训项目-俄亥俄州立大学
  • 批准号:
    8999685
  • 财政年份:
    2011
  • 资助金额:
    $ 29.79万
  • 项目类别:
Medical Scientist Training Program - Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
  • 批准号:
    8689090
  • 财政年份:
    2011
  • 资助金额:
    $ 29.79万
  • 项目类别:
Medical Scientist Training Program - Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
  • 批准号:
    8078747
  • 财政年份:
    2011
  • 资助金额:
    $ 29.79万
  • 项目类别:
Medical Scientist Training Program - Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
  • 批准号:
    8878287
  • 财政年份:
    2011
  • 资助金额:
    $ 29.79万
  • 项目类别:
Medical Scientist Training Program - Ohio State University
医学科学家培训计划 - 俄亥俄州立大学
  • 批准号:
    8278528
  • 财政年份:
    2011
  • 资助金额:
    $ 29.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了